Cargando…

Therapeutic drug monitoring of CT-P13: a comparison of four different immunoassays

BACKGROUND: The commercialization of CT-P13, an infliximab (IFX) biosimilar, has the potential to decrease health-related costs and enhance access to biological therapies. This study aimed to address the accuracy and inter-assay agreement of the CT-P13 quantification using four different assays init...

Descripción completa

Detalles Bibliográficos
Autores principales:	Afonso, Joana, de Sousa, Helena Tavares, Rosa, Isadora, Carvalho, João, Dias, Cláudia Camila, Magro, Fernando
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2017
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5598811/ https://www.ncbi.nlm.nih.gov/pubmed/28932268 http://dx.doi.org/10.1177/1756283X17722915

Ejemplares similares

Calprotectin and the Magnitude of Antibodies to Infliximab in Clinically-stable Ulcerative Colitis Patients are More Relevant Than Infliximab Trough Levels and Pharmacokinetics for Therapeutic Escalation
por: Magro, Fernando, et al.
Publicado: (2017)

Detection of anti-infliximab antibodies is impacted by antibody titer, infliximab level and IgG4 antibodies: a systematic comparison of three different assays
por: Afonso, Joana, et al.
Publicado: (2016)

Clinical performance of an infliximab rapid quantification assay
por: Magro, Fernando, et al.
Publicado: (2017)

Accuracy of the new rapid test for monitoring adalimumab levels
por: Rocha, Cátia, et al.
Publicado: (2019)

How many biomarker measurements are needed to predict prognosis in Crohn's disease patients under infliximab?—A prospective study
por: Magro, Fernando, et al.
Publicado: (2023)

Ileal Crohn's Disease Exhibits Similar Transmural Fibrosis Irrespective of Phenotype
por: Tavares de Sousa, Helena, et al.
Publicado: (2021)

Comparative Evaluation of Four Commercially Available Immunoassays for Therapeutic Drug Monitoring of Infliximab and Adalimumab
por: Rissel, Florian, et al.
Publicado: (2023)

Rapid test detection of anti-infliximab antibodies: performance comparison with three different immunoassays
por: Rocha, Cátia, et al.
Publicado: (2020)

How to Evaluate Fibrosis in IBD?
por: Tavares de Sousa, Helena, et al.
Publicado: (2023)

Adherence to glucose monitoring with intermittently scanned continuous glucose monitoring in patients with type 1 diabetes
por: Sousa, Carolina, et al.
Publicado: (2022)

The risk of disabling, surgery and reoperation in Crohn’s disease – A decision tree-based approach to prognosis
por: Dias, Cláudia Camila, et al.
Publicado: (2017)

Critical Appraisal of Four IL-6 Immunoassays
por: Thompson, Dana K., et al.
Publicado: (2012)

Aminosalicylates and COVID-19: Facts or Coincidences?
por: Magro, Fernando, et al.
Publicado: (2021)

Fecal Dipeptidyl Peptidase-4: An Emergent Biomarker in Inflammatory Bowel Disease
por: Pinto-Lopes, Pedro, et al.
Publicado: (2021)

Monitoring Crohn’s disease activity: endoscopy, fecal markers and computed tomography enterography
por: Lopes, Susana, et al.
Publicado: (2018)

Age at Diagnosis Is Determinant for the Outcome of Inflammatory Bowel Disease: Is It a Myth?
por: Ministro, Paula, et al.
Publicado: (2021)

Comparison of a novel automated DiaSys procalcitonin immunoassay with four different BRAHMS-partnered immunoassays
por: Eidizadeh, Abass, et al.
Publicado: (2022)

The performance of Remicade®-optimized quantification assays in the assessment of Flixabi® levels
por: Magro, F., et al.
Publicado: (2018)

Comparison of four routinely used vitamin D automated immunoassays
por: Windrichova, Jindra, et al.
Publicado: (2021)

Short Inflammatory Bowel Disease Questionnaire: translation and validation to the Portuguese language
por: Roseira, Joana, et al.
Publicado: (2021)

Search for four top quark production in the single lepton final state in pp collisions at $\sqrt s$~=~13 TeV with the ATLAS detector
por: Magro, Jacopo
Publicado: (2021)

Multicenter Comparison of Four Automated Immunoassay Analyzers for Prostate Specific Antigen
por: Park, Dong Jin, et al.
Publicado: (2019)

Comparative Study of Four Coloured Nanoparticle Labels in Lateral Flow Immunoassay
por: Razo, Shyatesa C., et al.
Publicado: (2021)

Use of a commercial enzyme immunoassay to monitor dengue virus replication in cultured cells
por: Ludert, Juan E, et al.
Publicado: (2008)

Evaluation of the Usefulness of an Automatable Immunoassay for Monitoring Celiac Disease by Quantification of Immunogenic Gluten Peptides in Urine
por: Segura, Verónica, et al.
Publicado: (2023)

Thiopurines’ Metabolites and Drug Toxicity: A Meta-Analysis
por: Sousa, Paula, et al.
Publicado: (2020)

Evaluation of the Cross-reactivity of Antidrug Antibodies to CT-P13 and Infliximab Reference Product (Remicade): An Analysis Using Immunoassays Tagged with Both Agents
por: Reinisch, Walter, et al.
Publicado: (2017)

Search for four-top-quark production in the single-lepton and opposite-sign dilepton final states in proton-proton collisions at $\sqrt {s}$ = 13 TeV with the ATLAS detector
por: Magro, J
Publicado: (2020)

Correcting for enzyme immunoassay changes in long term monitoring studies
por: Wilson, Abbey E., et al.
Publicado: (2021)

Performance evaluation of enzyme immunoassay for voriconazole therapeutic drug monitoring with automated clinical chemistry analyzers
por: Jeon, Yongbum, et al.
Publicado: (2017)

Transmural remission improves clinical outcomes up to 5 years in Crohn's disease
por: Fernandes, Samuel Raimundo, et al.
Publicado: (2022)

Diagnostic performance of four lateral flow immunoassays for COVID-19 antibodies in Peruvian population
por: Calderon-Flores, Rodrigo, et al.
Publicado: (2023)

Fecal marker levels as predictors of need for endoscopic balloon dilation in Crohn’s disease patients with anastomotic strictures
por: Lopes, Susana, et al.
Publicado: (2017)

Endothelitis profile in acute heart failure and cardiogenic shock patients: Endocan as a potential novel biomarker and putative therapeutic target
por: Reina-Couto, Marta, et al.
Publicado: (2022)

His-tag protein monitoring by a fast mix-and-measure immunoassay
por: Kreisig, Thomas, et al.
Publicado: (2014)

Noninvasive Urine Biomarker Lateral Flow Immunoassay for Monitoring Active Onchocerciasis
por: Shirey, Ryan J., et al.
Publicado: (2018)

Integrated Bioluminescent Immunoassays for High-Throughput Sampling and Continuous Monitoring of Cytokines
por: van Aalen, Eva A., et al.
Publicado: (2023)

Has the therapeutical ceiling been reached in Crohn's disease randomized controlled trials? A systematic review and meta‐analysis
por: Magro, Fernando, et al.
Publicado: (2023)

Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumab
por: Magro, Fernando, et al.
Publicado: (2019)

Exploring the Ways of “The Great Imitator”: A Case Report of Syphilitic Hepatitis
por: Cunha Neves, João A., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v738re6rteq5cb8k2lfl8d29cp